The Institute for Research in Biomedicine was founded in 2000 with the goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense. The IRB benefits from a wide international network of collaborations. In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.
Information on Coronavirus
What are the main precautions and the recommendations from the authorities? Latest information on the coronavirus:
World Health Organisation ; World Health Organisation Europe ; Canton Ticino ; Swiss Confederation ;
NewsAll news
 |
20.05.2020 The IRB at the forefront of the COVID serological tests in Ticino - first results The Institute for Biomedicine Research (IRB, affiliated to the USI) and Humabs BioMed (a subsidiary of Vir Biotechnology) joint their forces and expertise to test in the... Read more |
 |
07.05.2020 New paper from Cejka's Lab CtIP has emerged as one of the main factors that drives the processing of broken DNA into the homologous recombination pathway. CtIP achieves that by stimulating the... Read more |
 |
28.04.2020 Prof. Giorgio Noseda, Honorary President of the IRB Foundation, appointed honorary senator of the University of Zurich On April 25, 2020, at the annual Dies academicus of the University of Zurich (UZH), Prof. Giorgio Noseda has been appointed honorary senator of the University in... Read more |
 |
03.04.2020 New paper from Cejka's Lab : CtIP promotes DNA break repair When DNA breaks, cells need to join the broken DNA pieces in an accurate way to prevent mutations. Cells utilize the so-called homologous recombination pathway to... Read more |
 |
16.03.2020 A molecular network to balance inflammatory programs in immune cells A research team led by the Institute for Research in Biomedicine (IRB) in Bellinzona, affiliated to the Università della Svizzera italiana, has identified a molecular... Read more |
